Sasol International Chemicals Achieves Beneficial Operation of ISOSIV Paraffin Unit in Italy

Sasol International Chemicals, a business of Sasol Ltd. (JSE: SOL; NYSE: SSL), announced today beneficial operation of its previously idled ISOSIV paraffin production unit in Augusta, Italy.

The ISOSIV unit produces normal paraffin, a critical feedstock in the manufacture of DETAL Linear Alkylbenzene (LAB) and Linear Alkyl Sulfonate (LAS), raw materials used in the production of household cleaning products and laundry detergents.

In April of this year, Sasol International Chemicals declared force majeure on DETAL LAB, LAS and downstream derivatives based on DETAL LAB – a decision driven by geopolitical tensions affecting its Italy and Germany sites. Following beneficial operation of the ISOSIV unit, and the resulting improvement in supply reliability, Sasol International Chemicals is lifting force majeure on these products.

“This restart reinforces the strategic value of our regional manufacturing footprint and enhances our ability to support customers in key markets. It reflects a disciplined, market-based decision aligned with current demand and business priorities and forms an important part of our strategy,” said Antje Gerber, Executive Vice President of Sasol International Chemicals.

“Increasing our normal paraffin production capacity strengthens our global manufacturing footprint and enhances supply continuity across our asset base,” said Omar Espinosa, Senior Vice President of Commercial for Sasol International Chemicals. “This milestone supports our customers by strengthening the integrated operations and regional manufacturing capabilities that help enable secure, reliable and responsive supply.”

The additional available capacity enhances the company’s integrated value chain while increasing manufacturing capabilities for Care Chemicals applications.

You May Also Be Interested In

• Kotak Upgrades Escorts Kubota Ltd (ESCORTS:IN) to Buy (1)
• Axis Capital Limited Upgrades Atlanta Electricals (ATLANTAE:IN) to Buy (1)
• JPMorgan Downgrades Verra Mobility (VRRM) to Underweight